How has Aurinia Pharmaceuticals's accrued manufacturing costs changed year-over-year?

Aurinia Pharmaceuticals's accrued manufacturing costs increased by 40.0% year-over-year, from $6.16M to $8.62M.

What is the long-term trend for Aurinia Pharmaceuticals's accrued manufacturing costs?

Over 5 years (2020 to 2025), Aurinia Pharmaceuticals's accrued manufacturing costs has grown at a 10.7% compound annual growth rate (CAGR), from $11.36M to $18.87M.

Aurinia Pharmaceuticals AUPH Accrued Manufacturing Costs

Accrued Manufacturing Costs at other companies

ANI PharmaceuticalsANIP

——

Agios PharmaceuticalsAGIO

——

Arrowhead ResearchARWR

——

Mirum Pharmaceuticals, Inc.MIRM

——

Ligand PharmaceuticalsLGND

——

BridgeBio PharmaBBIO

——

Other financials

Income statement

See full

Revenue$77.7M+24.4%

Gross profit$71.2M+32.1%

Operating income$41.4M+89.6%

Net income$34.4M+47.2%

EPS (diluted)$0.25+56.3%

Balance sheet

See full

Cash & equivalents$41.0M-38.3%

Total debt$85.2M-7.9%

Total equity$567.6M+62.1%

Total assets$724.0M+43.4%

Cash flow

See full

Operating cash flow$32.6M+2,405%

Valuation

See full

Market cap$2.39B+78.5%

Profitability

See full

Gross margin89.7%+1.5pp

Operating margin41.7%+29.4pp

Net margin100%+83.9pp

Returns & leverage

See full

Return on equity65%+53.8pp

Debt / equity0.2×-0.1×

Current ratio5.5×-0.4×

Where this comes from

Reported directly by Aurinia Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aurinia Pharmaceuticals's accrued manufacturing costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Aurinia Pharmaceuticals's accrued manufacturing costs?: Aurinia Pharmaceuticals (AUPH) reported accrued manufacturing costs of $8.62M in Q1 2026.
How has Aurinia Pharmaceuticals's accrued manufacturing costs changed year-over-year?: Aurinia Pharmaceuticals's accrued manufacturing costs increased by 40.0% year-over-year, from $6.16M to $8.62M.
What is the long-term trend for Aurinia Pharmaceuticals's accrued manufacturing costs?: Over 5 years (2020 to 2025), Aurinia Pharmaceuticals's accrued manufacturing costs has grown at a 10.7% compound annual growth rate (CAGR), from $11.36M to $18.87M.